SCHEMBL6168891

SCHEMBL6168891

COc1ccc2[nH]c(C(=O)c3cc(C)ccn3)c(C(C)C(=O)O)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.67
PTGS1 P23219 7/20 0.67
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171969 0.92 PTGS2 (0.67) PTGS2PTGS1KDM4EALDH1A1HPGD
SCHEMBL6170712 0.89 PTGS2 (0.53) PTGS2PTGS1KDM4EALDH1A1HPGD
SCHEMBL6171784 0.88 PTGS2 (0.69) PTGS2PTGS1KDM4EMEN1KMT2A
SCHEMBL6172560 0.85 PTGS2 (0.50) PTGS2PTGS1KDM4EGAA
SCHEMBL6169271 0.85 PTGS2 (0.66) PTGS2PTGS1GABRA1GABRG2GABRB3
SCHEMBL6169472 0.85 PTGS2 (0.48) PTGS2PTGS1KDM4EALDH1A1HPGD
SCHEMBL6171838 0.84 PTGS2 (0.67) PTGS2PTGS1GABRA1GABRG2GABRB3
SCHEMBL7202770 0.84 PTGS2 (0.48) PTGS2PTGS1KDM4EALDH1A1HPGD
SCHEMBL6174674 0.84 PTGS2 (0.68) PTGS2PTGS1KDM4EALDH1A1HPGD
SCHEMBL6171485 0.83 PTGS2 (0.56) PTGS2PTGS1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US claimed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed